title: Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I.
authors.forename: T
authors.initials: T
authors.lastname: Chikama
authors.forename: K
authors.initials: K
authors.lastname: Fukuda
authors.forename: N
authors.initials: N
authors.lastname: Morishige
authors.forename: T
authors.initials: T
authors.lastname: Nishida
mesh_terms: D003316:Corneal Diseases / Q000188:drug therapy* / Q000209:etiology; D003389:Cranial Nerve Diseases / Q000150:complications; D004359:Drug Therapy, Combination; D019573:Epithelium, Corneal / Q000187:drug effects; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000627:therapeutic use*; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D010243:Paralysis / Q000150:complications; D014276:Trigeminal Nerve; D014792:Visual Acuity; D014945:Wound Healing / Q000187:drug effects
chemical_list: D009842:Oligopeptides; C112946:phenylalanyl-glycyl-leucyl-methioninamide; D007334:Insulin-Like Growth Factor I